Skip to main content
  • Sign in
    Welcome !
    My account
    Logout

NEKTAR THERAPEUTICS (NKTR) Stock Forecast 2025 - AI Price Prediction & Analysis

NEKTAR THERAPEUTICS (NKTR) AI Stock Price Forecast & Investment Analysis

NEKTAR THERAPEUTICS Stock Price Chart and Technical Analysis

Loading NEKTAR THERAPEUTICS interactive price chart and technical analysis...

NEKTAR THERAPEUTICS (NKTR) - Comprehensive Stock Analysis & Investment Research

Deep dive into NEKTAR THERAPEUTICS's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about NEKTAR THERAPEUTICS, including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For NEKTAR THERAPEUTICS: NEKTAR THERAPEUTICS operates in the Life Sciences sector, making it an emerging small-cap investment.

NEKTAR THERAPEUTICS (Stock Symbol: NKTR) is a leading company in the Life Sciences sector , specifically operating within the Pharmaceutical Preparations industry.

The organization employs approximately 820 professionals worldwide .

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing NEKTAR THERAPEUTICS's revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For NEKTAR THERAPEUTICS: With $74M in annual revenue and -318.9% net margin, the company demonstrates developing profitability.

Annual Revenue: $74 million generating a -318.9% net profit margin .

Market Capitalization: $787 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): -61.3% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for NEKTAR THERAPEUTICS stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Spearman correlation coefficient shows the statistical relationship between predictions and actual outcomes.

For NEKTAR THERAPEUTICS: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for NEKTAR THERAPEUTICS stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: NEKTAR THERAPEUTICS's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For NEKTAR THERAPEUTICS: Market positioning analysis based on available financial and operational metrics.

NEKTAR THERAPEUTICS strategically competes in the highly dynamic Pharmaceutical Preparations marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

The company maintains a healthy 23.7% gross margin, indicating strong pricing power and operational efficiency.

NEKTAR THERAPEUTICS (NKTR) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for NEKTAR THERAPEUTICS stock analysis.

Loading NEKTAR THERAPEUTICS comprehensive fundamental analysis and insider trading data...

Deep dive into NEKTAR THERAPEUTICS's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if NEKTAR THERAPEUTICS stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For NEKTAR THERAPEUTICS: With a P/E ratio of -1.16, the market sees the stock as potentially undervalued.

P/E Ratio -1.16x
P/B Ratio 337.85x
Market Cap $787M
EPS $-8.67
Book Value/Share $0.07
Revenue/Share $6.02
FCF/Share $-1.96
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently NEKTAR THERAPEUTICS converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For NEKTAR THERAPEUTICS: An ROE of -61.3% indicates room for improvement in shareholder value creation.

ROE -61.3%
ROA -39.6%
ROIC -49.3%
Gross Margin 23.7%
Operating Margin -299.7%
Net Margin -318.9%
EBT Margin -476.0%
Tax Rate 0.2%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess NEKTAR THERAPEUTICS's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For NEKTAR THERAPEUTICS: A current ratio of 6.97 indicates strong liquidity.

Current Ratio 6.97x
Quick Ratio 6.62x
D/E Ratio 0.20x
Financial Leverage 1.68x
Interest Coverage -10.8x
Working Capital $1022M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal NEKTAR THERAPEUTICS's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For NEKTAR THERAPEUTICS: Free cash flow of $-440M indicates cash challenges that need attention.

Operating Cash Flow $-424M
Free Cash Flow $-440M
Capital Spending $-16M
FCF/Sales -427.2%
CapEx/Sales 15.8%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively NEKTAR THERAPEUTICS uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For NEKTAR THERAPEUTICS: An asset turnover of 0.08x suggests room for improvement in asset utilization.

Asset Turnover 0.08x
Receivables Turnover 3.5x
Inventory Turnover 1.5x
Fixed Assets Turnover 0.6x
Days Sales Outstanding 105 days
Days Inventory 240 days
Payables Period 262 days
Cash Conversion Cycle 84 days
Understanding Financial Statement Data

What these metrics mean: Key figures from NEKTAR THERAPEUTICS's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For NEKTAR THERAPEUTICS: With annual revenue of $74M, NEKTAR THERAPEUTICS represents a smaller but potentially high-growth operation.

Income Statement ($ Millions)
Total Revenue $74M
Operating Income $-135M
Net Income $-144M
R&D Expense $121M
SG&A Expense $115M
Cost of Goods Sold $30M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 72%
Cash & Short-term Investments 65%
Total Liabilities 41%
Short-term Debt 13%
Accounts Receivable 3%
Inventory 2%
Dividend & Shareholder Information
Shares Outstanding 12M
Growth Metrics (YoY)
EPS Growth -84.7%

Latest NEKTAR THERAPEUTICS Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting NEKTAR THERAPEUTICS (NKTR) stock price and investment outlook.

, source: Nasdaq

Nektar Therapeutics (NASDAQ:NKTR) will release its quarterly earnings report on Thursday, 2025-05-08. Here's a brief overview for investors ahead of the announcement. Analysts anticipate Nektar ...

, source: Nasdaq

That said, Nektar hasn't released phase 2 top-line data for rezpegaldesleukin in alopecia areata yet -- it's due at the end of the year -- let alone initiated phase 3 in either atopic dermatitis or ...

NEKTAR THERAPEUTICS Competitors & Peer Analysis - Life Sciences Sector

Comparative analysis of NEKTAR THERAPEUTICS against industry peers and competitors in the Life Sciences sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
AARD Unlock Forecast - 30 Days FREE Trial $227M x 1.7x
ABBV Unlock Forecast - 30 Days FREE Trial $404370M 107.4x 0.0x
ABCL Unlock Forecast - 30 Days FREE Trial $1662M -5.3x 1.7x
ABEO Unlock Forecast - 30 Days FREE Trial $260M -2.5x 1.6x
ABT Unlock Forecast - 30 Days FREE Trial $218068M 15.8x 4.3x
ABUS Unlock Forecast - 30 Days FREE Trial $936M -8.3x 11.3x
ACAD Unlock Forecast - 30 Days FREE Trial $3799M 16.2x 4.6x
ACET Unlock Forecast - 30 Days FREE Trial $82M -0.4x 0.6x
ACRS Unlock Forecast - 30 Days FREE Trial $270M -4.5x 2.1x
ACRV Unlock Forecast - 30 Days FREE Trial $57M -2.8x 0.4x
ACTU Unlock Forecast - 30 Days FREE Trial $153M x -24.1x
ACUT Unlock Forecast - 30 Days FREE Trial $25M x x
ACXP Unlock Forecast - 30 Days FREE Trial $10M -0.8x 2.8x
ADAG Unlock Forecast - 30 Days FREE Trial $104M x 2.7x
ADCT Unlock Forecast - 30 Days FREE Trial $529M -9.2x -1.3x
ADIL Unlock Forecast - 30 Days FREE Trial $8M -0.1x 1.4x
ADTX Unlock Forecast - 30 Days FREE Trial $1M 0.0x 0.1x
AGIO Unlock Forecast - 30 Days FREE Trial $2435M 3.7x 1.8x
AIMD Unlock Forecast - 30 Days FREE Trial $17M -0.4x 1.5x
AKBA Unlock Forecast - 30 Days FREE Trial $575M -5.4x 19.7x
AKRO Unlock Forecast - 30 Days FREE Trial $4316M -8.7x 4.2x
AKTX Unlock Forecast - 30 Days FREE Trial $52184M -2.0x 2038.0x
ALDX Unlock Forecast - 30 Days FREE Trial $302M -5.1x 5.5x
ALLR Unlock Forecast - 30 Days FREE Trial $21M -0.2x 1.7x
ALMS Unlock Forecast - 30 Days FREE Trial $303M x 0.6x
ALNY Unlock Forecast - 30 Days FREE Trial $59248M -224.3x 253.3x
ALT Unlock Forecast - 30 Days FREE Trial $346M -5.7x 2.2x
ALXO Unlock Forecast - 30 Days FREE Trial $80M -0.4x 1.3x
ALZN Unlock Forecast - 30 Days FREE Trial $7M -0.1x 1.3x
AMLX Unlock Forecast - 30 Days FREE Trial $1238M -1.5x 7.4x
AMPH Unlock Forecast - 30 Days FREE Trial $1134M 8.5x 2.6x
AMRN Unlock Forecast - 30 Days FREE Trial $6822M -4.5x 14.9x
AMRX Unlock Forecast - 30 Days FREE Trial $3371M 1010.7x 0.0x
ANAB Unlock Forecast - 30 Days FREE Trial $1039M -2.5x 23.8x
ANEB Unlock Forecast - 30 Days FREE Trial $109M -4.3x 8.1x
ANIP Unlock Forecast - 30 Days FREE Trial $1861M 103.2x 4.3x
ANNX Unlock Forecast - 30 Days FREE Trial $438M -4.1x 2.2x
ANRO Unlock Forecast - 30 Days FREE Trial $165M x 1.3x
APLS Unlock Forecast - 30 Days FREE Trial $3792M -13.6x 24.3x
APRE Unlock Forecast - 30 Days FREE Trial $9M -1.2x 0.7x
APUS Unlock Forecast - 30 Days FREE Trial $23M x 2.4x
AQST Unlock Forecast - 30 Days FREE Trial $682M -10.7x -6.9x
ARCT Unlock Forecast - 30 Days FREE Trial $262M -7.0x 1.1x
ARDX Unlock Forecast - 30 Days FREE Trial $1226M -21.3x 8.8x
ARQT Unlock Forecast - 30 Days FREE Trial $3042M -6.6x 19.3x
ARTL Unlock Forecast - 30 Days FREE Trial $3M -0.7x 42.0x
ARVN Unlock Forecast - 30 Days FREE Trial $732M -4.8x 1.2x
ARWR Unlock Forecast - 30 Days FREE Trial $5566M -4.7x 10.7x
ASBP Unlock Forecast - 30 Days FREE Trial $17M x x
ASMB Unlock Forecast - 30 Days FREE Trial $231M -1.5x 12.8x
ASRT Unlock Forecast - 30 Days FREE Trial $79M -0.2x 0.9x
ATAI Unlock Forecast - 30 Days FREE Trial $1227M -4.4x 8.5x
ATXI Unlock Forecast - 30 Days FREE Trial $2M -9.5x 0.6x
ATXS Unlock Forecast - 30 Days FREE Trial $706M -4.7x 2.7x
AUPH Unlock Forecast - 30 Days FREE Trial $1624M 26.0x 4.8x
AVBP Unlock Forecast - 30 Days FREE Trial $707M x 2.8x
AVDL Unlock Forecast - 30 Days FREE Trial $1821M -10.2x 20.1x
AVTX Unlock Forecast - 30 Days FREE Trial $190M -0.1x 1.8x
AXSM Unlock Forecast - 30 Days FREE Trial $6642M -19.9x 90.9x
BBIO Unlock Forecast - 30 Days FREE Trial $12833M -11.6x -5.4x
BCAX Unlock Forecast - 30 Days FREE Trial $892M x 2.1x
BCTX Unlock Forecast - 30 Days FREE Trial $22M -1.7x 1.3x
BCYC Unlock Forecast - 30 Days FREE Trial $607M -6.0x 1.0x
BEIGF Unlock Forecast - 30 Days FREE Trial $38633M x 10.3x
BFRG Unlock Forecast - 30 Days FREE Trial $14M -2.9x 6.5x
BFRI Unlock Forecast - 30 Days FREE Trial $10M -0.1x 17.9x
BHC Unlock Forecast - 30 Days FREE Trial $2186M 24.1x -2.0x
BHVN Unlock Forecast - 30 Days FREE Trial $1938M -4.6x 14.4x
BIOA Unlock Forecast - 30 Days FREE Trial $277M x 0.9x
BIVI Unlock Forecast - 30 Days FREE Trial $4M -0.6x 0.2x
BLTE Unlock Forecast - 30 Days FREE Trial $2857M x 31.6x
BMEA Unlock Forecast - 30 Days FREE Trial $91M -1.6x 3.3x
BMRN Unlock Forecast - 30 Days FREE Trial $9962M 15.9x 1.7x
BMY Unlock Forecast - 30 Days FREE Trial $93019M 17.7x 5.0x
BMYMP Unlock Forecast - 30 Days FREE Trial $1498665M 296.8x 86.0x
BNTC Unlock Forecast - 30 Days FREE Trial $424M -0.6x 4.4x
BOLD Unlock Forecast - 30 Days FREE Trial $31M -15.1x 0.3x
BYSI Unlock Forecast - 30 Days FREE Trial $71M x -3.1x
CALC Unlock Forecast - 30 Days FREE Trial $45M 0.4x 7.4x
CAMP Unlock Forecast - 30 Days FREE Trial $59M -0.1x 1.5x
CANF Unlock Forecast - 30 Days FREE Trial $1984M x 474.1x
CARM Unlock Forecast - 30 Days FREE Trial $2M -0.7x 0.0x
CASI Unlock Forecast - 30 Days FREE Trial $27M -1.4x 14.6x
CATX Unlock Forecast - 30 Days FREE Trial $196M -2.8x 0.7x
CBIO Unlock Forecast - 30 Days FREE Trial $174M -6.5x 1.3x
CDT Unlock Forecast - 30 Days FREE Trial $8M -0.7x 2.4x
CING Unlock Forecast - 30 Days FREE Trial $18M -0.6x 3.3x
CLCS Unlock Forecast - 30 Days FREE Trial $17M x x
CLNN Unlock Forecast - 30 Days FREE Trial $79M -7.3x -6.9x
CLSD Unlock Forecast - 30 Days FREE Trial $298M -2.0x -0.7x
CLYM Unlock Forecast - 30 Days FREE Trial $157M -1.4x 0.9x
CMMB Unlock Forecast - 30 Days FREE Trial $1374M 10.9x 141.7x
CMPS Unlock Forecast - 30 Days FREE Trial $618M 0.0x 3.8x
CNSP Unlock Forecast - 30 Days FREE Trial $5M 0.0x 0.4x
CNTA Unlock Forecast - 30 Days FREE Trial $3211M -11.0x 9.3x
CNTB Unlock Forecast - 30 Days FREE Trial $96M x 1.4x
CNTX Unlock Forecast - 30 Days FREE Trial $129M -1.5x 1.6x
COGT Unlock Forecast - 30 Days FREE Trial $1823M -3.7x 11.8x
CORT Unlock Forecast - 30 Days FREE Trial $8662M 50.6x 13.6x
COYA Unlock Forecast - 30 Days FREE Trial $105M -6.8x 3.7x
CPHI Unlock Forecast - 30 Days FREE Trial $6M -0.2x 0.9x
CPIX Unlock Forecast - 30 Days FREE Trial $52M -4.5x 1.9x
CPRX Unlock Forecast - 30 Days FREE Trial $2571M 12.3x 3.0x
CRMD Unlock Forecast - 30 Days FREE Trial $879M 14.9x 4.0x
CRNX Unlock Forecast - 30 Days FREE Trial $4038M -15.9x 3.5x
CRVO Unlock Forecast - 30 Days FREE Trial $66M -0.7x 2.0x
CRVS Unlock Forecast - 30 Days FREE Trial $575M -13.7x 7.2x
CTMX Unlock Forecast - 30 Days FREE Trial $361M 7.7x 3.0x
CTNM Unlock Forecast - 30 Days FREE Trial $204M x 1.0x
CTOR Unlock Forecast - 30 Days FREE Trial $122M 3.9x 3.8x
CTXR Unlock Forecast - 30 Days FREE Trial $21M -5.3x 0.3x
CVKD Unlock Forecast - 30 Days FREE Trial $27M -11.1x 6.4x
CVSI Unlock Forecast - 30 Days FREE Trial $7M x 4.1x
CYDY Unlock Forecast - 30 Days FREE Trial $302M 86.7x x
CYRX Unlock Forecast - 30 Days FREE Trial $460M 7.2x 0.9x
CYTK Unlock Forecast - 30 Days FREE Trial $7M -9.4x -13.9x
DARE Unlock Forecast - 30 Days FREE Trial $18M 2.9x -2.3x
DAWN Unlock Forecast - 30 Days FREE Trial $727M -8.9x 1.6x
DERM Unlock Forecast - 30 Days FREE Trial $171M 24.1x 8.9x
DMAC Unlock Forecast - 30 Days FREE Trial $302M -4.2x 11.1x
DNTH Unlock Forecast - 30 Days FREE Trial $1096M -3.2x 3.6x
DRMA Unlock Forecast - 30 Days FREE Trial $3M -0.2x 0.5x
DRRX Unlock Forecast - 30 Days FREE Trial $59M -1.2x 17.0x
DSGN Unlock Forecast - 30 Days FREE Trial $372M -7.6x 1.8x
DVAX Unlock Forecast - 30 Days FREE Trial $1213M 88.2x 2.5x
DWTX Unlock Forecast - 30 Days FREE Trial $11M -2.9x 1.6x
DYN Unlock Forecast - 30 Days FREE Trial $2702M -7.8x 4.7x
EBS Unlock Forecast - 30 Days FREE Trial $660M 3.8x 1.1x
ELAN Unlock Forecast - 30 Days FREE Trial $11219M 25.4x 1.7x
ELTP Unlock Forecast - 30 Days FREE Trial $649M x 13.6x
ELVN Unlock Forecast - 30 Days FREE Trial $1398M -13.3x 2.9x
ENLV Unlock Forecast - 30 Days FREE Trial $25M x 1.3x
ENTA Unlock Forecast - 30 Days FREE Trial $232M -1.3x 2.9x
ENTO Unlock Forecast - 30 Days FREE Trial $24M 0.0x 0.3x
EOLS Unlock Forecast - 30 Days FREE Trial $434M -13.1x -89.8x
EPIX Unlock Forecast - 30 Days FREE Trial $9M -2.7x 0.1x
ERAS Unlock Forecast - 30 Days FREE Trial $708M -3.1x 1.9x
ESPR Unlock Forecast - 30 Days FREE Trial $572M -4.2x -0.2x
ETNB Unlock Forecast - 30 Days FREE Trial $2201M -3.5x 4.2x
ETON Unlock Forecast - 30 Days FREE Trial $488M -66.2x 20.4x
EWTX Unlock Forecast - 30 Days FREE Trial $1720M -19.7x 2.9x
FBLG Unlock Forecast - 30 Days FREE Trial $15M x 17.6x
FGEN Unlock Forecast - 30 Days FREE Trial $42M -0.2x -3.6x
FHTX Unlock Forecast - 30 Days FREE Trial $241M -3.3x -5.5x
FLGC Unlock Forecast - 30 Days FREE Trial $406M -4.2x 101.0x
FOLD Unlock Forecast - 30 Days FREE Trial $2742M -8.5x 13.4x
FULC Unlock Forecast - 30 Days FREE Trial $466M -36.1x 2.4x
GALT Unlock Forecast - 30 Days FREE Trial $325M -2.4x -1.6x
GBIO Unlock Forecast - 30 Days FREE Trial $42M -0.6x 0.8x
GERN Unlock Forecast - 30 Days FREE Trial $843M -11.9x 3.3x
GLMD Unlock Forecast - 30 Days FREE Trial $7M x 0.4x
GLSI Unlock Forecast - 30 Days FREE Trial $125M -17.2x 87.1x
GLTO Unlock Forecast - 30 Days FREE Trial $13M -2.5x 1.2x
GNLX Unlock Forecast - 30 Days FREE Trial $295M -2.8x 12.4x
GOSS Unlock Forecast - 30 Days FREE Trial $561M -3.2x -61.8x
GPCR Unlock Forecast - 30 Days FREE Trial $5361M -44.0x 6.9x
GRCE Unlock Forecast - 30 Days FREE Trial $43M -3.9x 0.7x
GRTX Unlock Forecast - 30 Days FREE Trial $1M -0.3x -0.1x
GYRE Unlock Forecast - 30 Days FREE Trial $703M 82.9x 7.6x
HCM Unlock Forecast - 30 Days FREE Trial $12835M x 10.4x
HMDCF Unlock Forecast - 30 Days FREE Trial $3194M x 2.6x
HOOK Unlock Forecast - 30 Days FREE Trial $11M -1.0x 0.3x
HOTH Unlock Forecast - 30 Days FREE Trial $19M -0.5x 1.9x
HOWL Unlock Forecast - 30 Days FREE Trial $73M -1.3x 1.8x
HRMY Unlock Forecast - 30 Days FREE Trial $1687M 9.6x 2.2x
HRTX Unlock Forecast - 30 Days FREE Trial $231M -6.4x -10.1x
IBIO Unlock Forecast - 30 Days FREE Trial $16M -0.4x 1.1x
IBO Unlock Forecast - 30 Days FREE Trial $7M x 6.5x
IDYA Unlock Forecast - 30 Days FREE Trial $2820M -12.2x 2.9x
IGC Unlock Forecast - 30 Days FREE Trial $34M -4.6x 5.5x
IMNM Unlock Forecast - 30 Days FREE Trial $1395M -2.4x 5.2x
IMRX Unlock Forecast - 30 Days FREE Trial $229M -0.8x 7.9x
IMUC Unlock Forecast - 30 Days FREE Trial $4M x 1.1x
IMUX Unlock Forecast - 30 Days FREE Trial $79M -0.8x 2.3x
INDP Unlock Forecast - 30 Days FREE Trial $2M -0.6x 66.4x
INDV Unlock Forecast - 30 Days FREE Trial $3155M 48.3x x
INM Unlock Forecast - 30 Days FREE Trial $4M -51.8x 0.3x
INO Unlock Forecast - 30 Days FREE Trial $86M -0.6x 3.0x
INSM Unlock Forecast - 30 Days FREE Trial $41288M -14.0x 43.7x
INVA Unlock Forecast - 30 Days FREE Trial $1120M 28.9x 2.0x
IOBT Unlock Forecast - 30 Days FREE Trial $43M -0.7x 27.1x
IONS Unlock Forecast - 30 Days FREE Trial $11583M -14.6x 18.7x
IRD Unlock Forecast - 30 Days FREE Trial $112M -2.0x 6.4x
IRON Unlock Forecast - 30 Days FREE Trial $2949M -18.4x 4.8x
IRWD Unlock Forecast - 30 Days FREE Trial $250M 64.7x -0.4x
ISCO Unlock Forecast - 30 Days FREE Trial $1M x x
IXHL Unlock Forecast - 30 Days FREE Trial $6M x 0.8x
JANX Unlock Forecast - 30 Days FREE Trial $1659M -63.7x 1.7x
JAZZ Unlock Forecast - 30 Days FREE Trial $8291M 14.3x 2.2x
JBIO Unlock Forecast - 30 Days FREE Trial $321M x 1.6x
JNJ Unlock Forecast - 30 Days FREE Trial $458408M 18.4x 5.8x
JUNS Unlock Forecast - 30 Days FREE Trial $55M x 41.3x
KALA Unlock Forecast - 30 Days FREE Trial $9M -0.5x 6.5x
KALV Unlock Forecast - 30 Days FREE Trial $558M -2.6x 13.7x
KAPA Unlock Forecast - 30 Days FREE Trial $21M x 3.4x
KNSA Unlock Forecast - 30 Days FREE Trial $2917M -64.7x 5.5x
KPRX Unlock Forecast - 30 Days FREE Trial $9M -2.4x 0.4x
KPTI Unlock Forecast - 30 Days FREE Trial $51M -0.6x -0.2x
KROS Unlock Forecast - 30 Days FREE Trial $614M -13.3x 0.9x
KRRO Unlock Forecast - 30 Days FREE Trial $348M -7.9x 1.6x
KURA Unlock Forecast - 30 Days FREE Trial $916M -4.5x 3.0x
KZR Unlock Forecast - 30 Days FREE Trial $47M -3.2x 0.5x
LEXX Unlock Forecast - 30 Days FREE Trial $16M -29.3x 2.9x
LIANY Unlock Forecast - 30 Days FREE Trial $7M x 0.0x
LIFD Unlock Forecast - 30 Days FREE Trial $4M x 0.1x
LIPO Unlock Forecast - 30 Days FREE Trial $3M -3.3x 1.0x
LLY Unlock Forecast - 30 Days FREE Trial $759797M 53.9x 31.9x
LQDA Unlock Forecast - 30 Days FREE Trial $1928M -7.2x 126.9x
LRMR Unlock Forecast - 30 Days FREE Trial $259M -0.8x 2.2x
LSTA Unlock Forecast - 30 Days FREE Trial $21M -1.0x 1.0x
LTRN Unlock Forecast - 30 Days FREE Trial $43M -2.4x 3.4x
LVTX Unlock Forecast - 30 Days FREE Trial $39M x 2.0x
LXRX Unlock Forecast - 30 Days FREE Trial $481M -1.2x 3.7x
LYEL Unlock Forecast - 30 Days FREE Trial $245M -1.1x 0.8x
MAIA Unlock Forecast - 30 Days FREE Trial $41M -1.4x 10.5x
MBIO Unlock Forecast - 30 Days FREE Trial $5M -0.1x 1.8x
MBX Unlock Forecast - 30 Days FREE Trial $730M x 3.3x
MDCX Unlock Forecast - 30 Days FREE Trial $38M x x
MDCXW Unlock Forecast - 30 Days FREE Trial $40M x x
MDGL Unlock Forecast - 30 Days FREE Trial $9368M -5.7x 13.5x
MGNX Unlock Forecast - 30 Days FREE Trial $104M -2.1x 2.2x
MIRA Unlock Forecast - 30 Days FREE Trial $28M -1.6x 49.4x
MIRM Unlock Forecast - 30 Days FREE Trial $3527M -20.0x 13.8x
MIST Unlock Forecast - 30 Days FREE Trial $104M -2.0x 4.2x
MLTX Unlock Forecast - 30 Days FREE Trial $636M -50.8x 1.8x
MLYS Unlock Forecast - 30 Days FREE Trial $2638M -4.5x 8.4x
MNKD Unlock Forecast - 30 Days FREE Trial $1697M 49.6x -20.2x
MNPR Unlock Forecast - 30 Days FREE Trial $535M -3.0x 10.3x
MREO Unlock Forecast - 30 Days FREE Trial $1501M x 27.7x
MRK Unlock Forecast - 30 Days FREE Trial $217598M 13.4x 4.4x
MRKR Unlock Forecast - 30 Days FREE Trial $12M -0.6x 1.1x
MRSN Unlock Forecast - 30 Days FREE Trial $49M -3.4x -1.4x
MRUS Unlock Forecast - 30 Days FREE Trial $7164M -13.5x 8.5x
MRVI Unlock Forecast - 30 Days FREE Trial $449M -5.6x 1.7x
MTSR Unlock Forecast - 30 Days FREE Trial $5476M x 12.2x
MTVA Unlock Forecast - 30 Days FREE Trial $24M -0.5x 2.5x
MURA Unlock Forecast - 30 Days FREE Trial $36M x 0.6x
NAMS Unlock Forecast - 30 Days FREE Trial $4032M x 5.2x
NAMSW Unlock Forecast - 30 Days FREE Trial $2773M x 3.6x
NATR Unlock Forecast - 30 Days FREE Trial $232M 17.6x 1.5x
NEUP Unlock Forecast - 30 Days FREE Trial $29M x 1.1x
NGNE Unlock Forecast - 30 Days FREE Trial $427M -7.3x 1.6x
NIKA Unlock Forecast - 30 Days FREE Trial $308M x x
NKTR Unlock Forecast - 30 Days FREE Trial $787M -1.2x 337.9x
NKTX Unlock Forecast - 30 Days FREE Trial $170M -1.3x 0.5x
NLSP Unlock Forecast - 30 Days FREE Trial $11M x 21.2x
NLSPW Unlock Forecast - 30 Days FREE Trial $0M x 0.3x
NRIX Unlock Forecast - 30 Days FREE Trial $986M -7.4x 2.7x
NRSN Unlock Forecast - 30 Days FREE Trial $29M x x
NTHI Unlock Forecast - 30 Days FREE Trial $169M x x
NUVB Unlock Forecast - 30 Days FREE Trial $1733M -1.2x 4.7x
NUVL Unlock Forecast - 30 Days FREE Trial $7386M -30.9x 7.9x
NVCT Unlock Forecast - 30 Days FREE Trial $147M -3.9x 8.7x
NWBO Unlock Forecast - 30 Days FREE Trial $348M x x
NXEN Unlock Forecast - 30 Days FREE Trial $1M x x
OCEA Unlock Forecast - 30 Days FREE Trial $0M -0.3x 0.0x
OCUL Unlock Forecast - 30 Days FREE Trial $1985M -8.2x 6.5x
OGN Unlock Forecast - 30 Days FREE Trial $1648M 3.4x 2.3x
OKUR Unlock Forecast - 30 Days FREE Trial $37M -6.9x 0.5x
OLMA Unlock Forecast - 30 Days FREE Trial $607M -4.0x 1.8x
OMER Unlock Forecast - 30 Days FREE Trial $451M -4.2x -0.9x
ONC Unlock Forecast - 30 Days FREE Trial $440201M x 116.8x
OPK Unlock Forecast - 30 Days FREE Trial $1078M -3.5x 0.8x
ORGO Unlock Forecast - 30 Days FREE Trial $531M -32.9x 2.3x
ORIC Unlock Forecast - 30 Days FREE Trial $1131M -4.2x 3.5x
ORKA Unlock Forecast - 30 Days FREE Trial $1036M x 3.0x
OSTX Unlock Forecast - 30 Days FREE Trial $55M x 11.1x
OTLC Unlock Forecast - 30 Days FREE Trial $41M x 4.9x
OVID Unlock Forecast - 30 Days FREE Trial $116M -2.6x 2.1x
OWPC Unlock Forecast - 30 Days FREE Trial $2M x x
PAHC Unlock Forecast - 30 Days FREE Trial $1676M 35.7x 5.9x
PBH Unlock Forecast - 30 Days FREE Trial $3025M 14.6x 1.6x
PBYI Unlock Forecast - 30 Days FREE Trial $273M 5.6x 2.6x
PCRX Unlock Forecast - 30 Days FREE Trial $956M -7534.1x 1.3x
PDSB Unlock Forecast - 30 Days FREE Trial $43M -1.7x 2.7x
PEPG Unlock Forecast - 30 Days FREE Trial $160M -1.6x 2.3x
PFE Unlock Forecast - 30 Days FREE Trial $138647M 13.1x 1.6x
PGEN Unlock Forecast - 30 Days FREE Trial $1203M -1.4x -37.0x
PHAT Unlock Forecast - 30 Days FREE Trial $1013M -1.6x -1.6x
PMHS Unlock Forecast - 30 Days FREE Trial $6M x 0.7x
PMN Unlock Forecast - 30 Days FREE Trial $14M -2.1x 2.1x
PMVP Unlock Forecast - 30 Days FREE Trial $74M -1.6x 0.5x
PPCB Unlock Forecast - 30 Days FREE Trial $18M x 1.0x
PRAX Unlock Forecast - 30 Days FREE Trial $4164M -4.0x 10.3x
PRFX Unlock Forecast - 30 Days FREE Trial $4M x x
PRGO Unlock Forecast - 30 Days FREE Trial $2928M -27.6x 0.7x
PRTA Unlock Forecast - 30 Days FREE Trial $573M -12.4x 1.8x
PTCT Unlock Forecast - 30 Days FREE Trial $5346M 8.4x -20.3x
PTGX Unlock Forecast - 30 Days FREE Trial $4763M 87.7x 7.1x
PVCT Unlock Forecast - 30 Days FREE Trial $32M x x
PVLA Unlock Forecast - 30 Days FREE Trial $854M x 17.9x
PYXS Unlock Forecast - 30 Days FREE Trial $215M -1.3x 2.5x
QNRX Unlock Forecast - 30 Days FREE Trial $307M x 120.1x
QURE Unlock Forecast - 30 Days FREE Trial $3873M -2.8x 24.4x
RAPP Unlock Forecast - 30 Days FREE Trial $990M x 3.8x
RAPT Unlock Forecast - 30 Days FREE Trial $793M -0.4x 4.8x
RARE Unlock Forecast - 30 Days FREE Trial $3333M -7.0x 22.0x
RCKT Unlock Forecast - 30 Days FREE Trial $399M -4.8x 1.1x
RCUS Unlock Forecast - 30 Days FREE Trial $2173M -5.5x 5.0x
REGN Unlock Forecast - 30 Days FREE Trial $71225M 14.2x 2.3x
REVB Unlock Forecast - 30 Days FREE Trial $2M -0.1x 0.5x
RFL Unlock Forecast - 30 Days FREE Trial $34M -0.9x 0.4x
RIGL Unlock Forecast - 30 Days FREE Trial $571M 5.7x 7.0x
RLYB Unlock Forecast - 30 Days FREE Trial $22M -0.7x 0.5x
RMTI Unlock Forecast - 30 Days FREE Trial $40M -17.1x 1.3x
RNA Unlock Forecast - 30 Days FREE Trial $8412M -12.2x 7.1x
RNAC Unlock Forecast - 30 Days FREE Trial $211M -2.1x -14.1x
RNAZ Unlock Forecast - 30 Days FREE Trial $13M -0.2x 2.1x
RNXT Unlock Forecast - 30 Days FREE Trial $41M -3.4x 3.9x
ROIV Unlock Forecast - 30 Days FREE Trial $12799M 1.8x 2.9x
RPRX Unlock Forecast - 30 Days FREE Trial $21062M 20.8x 3.3x
RPTX Unlock Forecast - 30 Days FREE Trial $79M -2.1x 0.7x
RTSL Unlock Forecast - 30 Days FREE Trial $0M 0.5x x
RVPH Unlock Forecast - 30 Days FREE Trial $39M -4.1x -4.3x
RYTM Unlock Forecast - 30 Days FREE Trial $7279M -20.3x 2603.1x
RZLT Unlock Forecast - 30 Days FREE Trial $835M -3.9x 5.2x
SAVA Unlock Forecast - 30 Days FREE Trial $208M -1.9x 2.4x
SCNX Unlock Forecast - 30 Days FREE Trial $9M 2.9x 0.1x
SCPH Unlock Forecast - 30 Days FREE Trial $302M -2.0x -50.9x
SCYX Unlock Forecast - 30 Days FREE Trial $30M -2.4x 0.7x
SDGR Unlock Forecast - 30 Days FREE Trial $1535M -7.8x 4.5x
SEPN Unlock Forecast - 30 Days FREE Trial $964M x 2.6x
SER Unlock Forecast - 30 Days FREE Trial $50M 22.6x 27.8x
SGMT Unlock Forecast - 30 Days FREE Trial $237M x 1.8x
SION Unlock Forecast - 30 Days FREE Trial $1649M x 4.9x
SKYE Unlock Forecast - 30 Days FREE Trial $43M -0.7x 1.0x
SLGL Unlock Forecast - 30 Days FREE Trial $113M x 3.6x
SLN Unlock Forecast - 30 Days FREE Trial $1034M x 11.0x
SLNCF Unlock Forecast - 30 Days FREE Trial $227M x 2.4x
SLNO Unlock Forecast - 30 Days FREE Trial $3528M -18.5x 14.7x
SLS Unlock Forecast - 30 Days FREE Trial $192M -1.0x 7.3x
SMMT Unlock Forecast - 30 Days FREE Trial $13876M 104.1x 72.2x
SNDX Unlock Forecast - 30 Days FREE Trial $1138M -4.1x 7.2x
SNNC Unlock Forecast - 30 Days FREE Trial $0M x x
SNSE Unlock Forecast - 30 Days FREE Trial $15M -0.4x 0.5x
SPRO Unlock Forecast - 30 Days FREE Trial $127M -17.8x 3.9x
SPRY Unlock Forecast - 30 Days FREE Trial $878M -23.5x 4.6x
SRPT Unlock Forecast - 30 Days FREE Trial $2291M 162.5x 1.7x
STOK Unlock Forecast - 30 Days FREE Trial $1765M 33.7x 5.3x
SUPN Unlock Forecast - 30 Days FREE Trial $3125M 46.0x 2.9x
SVRA Unlock Forecast - 30 Days FREE Trial $763M -8.2x 6.3x
SXTP Unlock Forecast - 30 Days FREE Trial $2M -0.6x 0.9x
SYBX Unlock Forecast - 30 Days FREE Trial $21M 3.6x 1.7x
SYRE Unlock Forecast - 30 Days FREE Trial $1460M -0.7x 3.2x
TBPH Unlock Forecast - 30 Days FREE Trial $720M 55.2x 3.2x
TCRT Unlock Forecast - 30 Days FREE Trial $6M -1.0x 1.7x
TELO Unlock Forecast - 30 Days FREE Trial $48M x 99.6x
TERN Unlock Forecast - 30 Days FREE Trial $739M -5.1x 2.4x
TEVA Unlock Forecast - 30 Days FREE Trial $23215M -13.9x 3.4x
TEVJF Unlock Forecast - 30 Days FREE Trial $23192M x 3.4x
TGTX Unlock Forecast - 30 Days FREE Trial $5338M 87.3x 19.3x
TNGX Unlock Forecast - 30 Days FREE Trial $889M -2.8x 6.6x
TNXP Unlock Forecast - 30 Days FREE Trial $147M 0.0x 0.9x
TOVX Unlock Forecast - 30 Days FREE Trial $4M -0.4x 0.1x
TRAW Unlock Forecast - 30 Days FREE Trial $20M -0.6x 1.8x
TRDA Unlock Forecast - 30 Days FREE Trial $262M 6.9x 0.7x
TRVI Unlock Forecast - 30 Days FREE Trial $1326M -6.1x 6.7x
TVRD Unlock Forecast - 30 Days FREE Trial $44M x 1.3x
TYRA Unlock Forecast - 30 Days FREE Trial $831M -9.5x 2.8x
UPB Unlock Forecast - 30 Days FREE Trial $1318M x 3.2x
URGN Unlock Forecast - 30 Days FREE Trial $912M -2.5x -15.2x
UTHR Unlock Forecast - 30 Days FREE Trial $19458M 15.5x 3.0x
VERA Unlock Forecast - 30 Days FREE Trial $1904M -20.4x 4.1x
VINC Unlock Forecast - 30 Days FREE Trial $0M -0.2x 0.1x
VKTX Unlock Forecast - 30 Days FREE Trial $3960M -67.5x 5.6x
VNDA Unlock Forecast - 30 Days FREE Trial $255M -16.1x 0.6x
VRCA Unlock Forecast - 30 Days FREE Trial $38M -0.5x -4.1x
VRDN Unlock Forecast - 30 Days FREE Trial $1934M -4.5x 3.8x
VREOF Unlock Forecast - 30 Days FREE Trial $268M x 1.0x
VRNA Unlock Forecast - 30 Days FREE Trial $73547M -185.1x 264.3x
VRTX Unlock Forecast - 30 Days FREE Trial $107615M 29.8x 6.3x
VSTM Unlock Forecast - 30 Days FREE Trial $553M -6.5x 15.3x
VTGN Unlock Forecast - 30 Days FREE Trial $129M -0.1x 2.3x
VTRS Unlock Forecast - 30 Days FREE Trial $12253M -29.5x 0.0x
VTVT Unlock Forecast - 30 Days FREE Trial $0M -3.3x -7.5x
VTYX Unlock Forecast - 30 Days FREE Trial $279M -1.0x 1.3x
VYNE Unlock Forecast - 30 Days FREE Trial $7M -0.4x 0.2x
WHWK Unlock Forecast - 30 Days FREE Trial $104M x 0.6x
WVE Unlock Forecast - 30 Days FREE Trial $1286M -22.2x 9.2x
XBIT Unlock Forecast - 30 Days FREE Trial $76M -3.5x 0.4x
XENE Unlock Forecast - 30 Days FREE Trial $3255M -15.4x 5.1x
XERS Unlock Forecast - 30 Days FREE Trial $1583M 385.0x -23.8x
XLO Unlock Forecast - 30 Days FREE Trial $39M -0.5x 5.5x
XNCR Unlock Forecast - 30 Days FREE Trial $1030M -8.4x 1.7x
XOMA Unlock Forecast - 30 Days FREE Trial $401M -11.7x 5.5x
XOMAO Unlock Forecast - 30 Days FREE Trial $307M -10.1x 4.2x
XOMAP Unlock Forecast - 30 Days FREE Trial $320M -10.5x 4.4x
ZBIO Unlock Forecast - 30 Days FREE Trial $1246M x 5.2x
ZLAB Unlock Forecast - 30 Days FREE Trial $27830M -95.2x 35.2x
ZOMDF Unlock Forecast - 30 Days FREE Trial $62M x 0.5x
ZTS Unlock Forecast - 30 Days FREE Trial $63973M 24.9x 12.9x
ZVRA Unlock Forecast - 30 Days FREE Trial $562M -55.3x 4.8x
ZYME Unlock Forecast - 30 Days FREE Trial $1457M -8.3x 4.4x

Frequently Asked Questions - NEKTAR THERAPEUTICS Stock Forecast

How accurate are NEKTAR THERAPEUTICS stock predictions?

Our AI model shows a 44% Spearman correlation coefficient for NKTR predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence NEKTAR THERAPEUTICS stock price forecasts?

Our analysis considers NEKTAR THERAPEUTICS's financial metrics, Life Sciences sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is NEKTAR THERAPEUTICS a good investment in 2025?

Based on our AI analysis, NEKTAR THERAPEUTICS shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are NEKTAR THERAPEUTICS forecasts updated?

NEKTAR THERAPEUTICS stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced NEKTAR THERAPEUTICS Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for NEKTAR THERAPEUTICS stock.

🎯 Get Premium Analysis 📊 Explore More Stocks

My Portfolio

Investment Dashboard

Loading your portfolio...